These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29116404)

  • 1. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.
    Burke MF; Burke FM; Soffer DE
    Curr Atheroscler Rep; 2017 Nov; 19(12):60. PubMed ID: 29116404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
    Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues.
    Sherratt SCR; Libby P; Budoff MJ; Bhatt DL; Mason RP
    Curr Atheroscler Rep; 2023 Jan; 25(1):1-17. PubMed ID: 36580204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
    Harris WS; Dayspring TD; Moran TJ
    Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review.
    Hilleman DE; Wiggins BS; Bottorff MB
    Adv Ther; 2020 Feb; 37(2):656-670. PubMed ID: 31919792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of prescription omega-3 fatty acid products for hypertriglyceridemia.
    Weintraub HS
    Postgrad Med; 2014 Nov; 126(7):7-18. PubMed ID: 25387209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients benefit from omega-3 fatty acids?
    Sherratt SCR; Mason RP; Libby P; Steg PG; Bhatt DL
    Cardiovasc Res; 2024 Feb; 119(18):2884-2901. PubMed ID: 38252923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
    Weintraub H
    Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and omega-3s: Prescription products and fish oil dietary supplements are not the same.
    Gutstein AS; Copple T
    J Am Assoc Nurse Pract; 2017 Dec; 29(12):791-801. PubMed ID: 29280361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.
    Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS
    Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence.
    Bhat S; Sarkar S; Zaffar D; Dandona P; Kalyani RR
    Curr Cardiol Rep; 2023 Feb; 25(2):51-65. PubMed ID: 36729217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 (
    Djuricic I; Calder PC
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease.
    Barry AR; Dixon DL
    Pharmacotherapy; 2021 Dec; 41(12):1056-1065. PubMed ID: 34431129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of linoleic acid on cardiometabolic health: an update.
    Jackson KH; Harris WS; Belury MA; Kris-Etherton PM; Calder PC
    Lipids Health Dis; 2024 Sep; 23(1):296. PubMed ID: 39267068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Omega-3 Fatty Acid Products and Dietary Supplements Are Not Interchangeable.
    Hilleman D; Smer A
    Manag Care; 2016 Jan; 25(1):46-52. PubMed ID: 26882630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.
    Tummala R; Ghosh RK; Jain V; Devanabanda AR; Bandyopadhyay D; Deedwania P; Aronow WS
    Am J Med; 2019 Oct; 132(10):1153-1159. PubMed ID: 31077653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.